Tea consumption and prostate cancer: an updated meta-analysis

Area of Science:

• Oncology
• Nutritional Epidemiology
• Preventive Medicine

Background:

• Tea consumption is widely believed to offer chemopreventive benefits against various cancers.
• The specific role of tea in mitigating prostate cancer risk remains a subject of ongoing scientific debate and investigation.

Purpose of the Study:

• To conduct a comprehensive meta-analysis to determine the association between tea consumption and the risk of developing prostate cancer.
• To clarify the controversial findings regarding tea's potential protective effects against prostate cancer.

Main Methods:

• A systematic literature search identified 21 relevant published articles.
• Pooled estimates of odds ratios (OR) and relative risks (RR) were calculated using random or fixed effect models.
• Stratified analyses were performed based on tea type, population demographics, and study design.

Main Results:

• The overall meta-analysis revealed no statistically significant association between tea consumption and prostate cancer risk (OR = 0.86, 95% CI: 0.69-1.04).
• Stratified analyses by population (Asian vs. non-Asian) and tea type (green vs. black tea) also showed non-significant results.
• A borderline protective effect was observed solely within the subgroup of case-control studies (OR = 0.77, 95% CI: 0.55-0.98).

Conclusions:

• The current meta-analysis does not provide sufficient evidence to conclude that tea consumption reduces prostate cancer risk.
• Further robust epidemiological studies are necessary to definitively establish any potential link or lack thereof.